A phase I bioavailability study of prodrug MPC 0767.
Latest Information Update: 14 May 2012
Price :
$35 *
At a glance
- Drugs MPC 0767 Myrexis (Primary)
- Indications Cancer
- Focus Pharmacokinetics
- 14 May 2012 Status changed from planning to suspended.
- 22 Sep 2011 New trial record